Abstract

Pulmonary hypertension (PH) includes multiple diseases that share as common characteristic an elevated pulmonary artery pressure and right ventricular involvement. Sex differences are observed in practically all causes of PH. The most studied type is pulmonary arterial hypertension (PAH) which presents a gender bias regarding its prevalence, prognosis, and response to treatment. Although this disease is more frequent in women, once affected they present a better prognosis compared to men. Even if estrogens seem to be the key to understand these differences, animal models have shown contradictory results leading to the birth of the estrogen paradox. In this review we will summarize the evidence regarding sex differences in experimental animal models and, very specially, in patients suffering from PAH or PH from other etiologies.

Highlights

  • Sex constitutes a non-modifiable risk marker for several diseases (Khamis et al, 2016; Mattiuzzi and Lippi, 2019) but in few of them its consequences represent such a challenge as in pulmonary hypertension (PH)

  • Complex mechanisms involving a dysregulation of nitric oxide, endothelin-1 production and the intervention of multiple cell types like pulmonary artery smooth muscle cells (PASMCs), pulmonary artery endothelial cells (PAEs) and fibroblasts constitute the hallmarks of pulmonary arterial hypertension (PAH), they are involved to a lesser or greater degree in all cases of PH (Humbert et al, 2019)

  • Sex differences are observed in practically all groups of PH

Read more

Summary

Sex Differences in Pulmonary Hypertension

Reviewed by: Stevan Tofovic, University of Pittsburgh, United States Sharath C. Sex differences are observed in practically all causes of PH. The most studied type is pulmonary arterial hypertension (PAH) which presents a gender bias regarding its prevalence, prognosis, and response to treatment. This disease is more frequent in women, once affected they present a better prognosis compared to men. Even if estrogens seem to be the key to understand these differences, animal models have shown contradictory results leading to the birth of the estrogen paradox. In this review we will summarize the evidence regarding sex differences in experimental animal models and, very specially, in patients suffering from PAH or PH from other etiologies

INTRODUCTION
OVERVIEW OF SEX HORMONES SYNTHESIS AND METABOLISM
THE SEX PARADOX IN PULMONARY ARTERIAL HYPERTENSION
Evidence From Experimental Animal Models of Pulmonary Arterial Hypertension
Evidence From Human Pulmonary Arterial Hypertension
SEX DIFFERENCES IN OTHER PULMONARY HYPERTENSION GROUPS
CONCLUSION
Findings
Survival in Incident and Prevalent Cohorts of Patients with Pulmonary Arterial
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call